authors
- Juergens, Rosalyn
- Ellis, Peter
- Tu, D
- Hao, D
- Laurie, S
- Mates, M
- Goss, G
- Goffin, John
- Bradbury, P
- Tehfe, M
- Kollmansberger, C
- Brown-Walker, P
- Smoragiewicz, M
- Tsao, M
- Seymour, L
MA11.04 Platinum Doublet + Durvalumab +/- Tremelimumab in Patients with Advanced NSCLC: A CCTG Phase IB Study - IND.226
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2019
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Thoracic Oncology Journal